NextPlat Corp. (NASDAQ:NXPL) Short Interest Update

by · The Cerbat Gem

NextPlat Corp. (NASDAQ:NXPL – Get Free Report) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 518,283 shares, an increase of 227.4% from the February 12th total of 158,290 shares. Based on an average daily trading volume, of 1,458,650 shares, the short-interest ratio is currently 0.4 days. Currently, 3.5% of the shares of the company are short sold. Currently, 3.5% of the shares of the company are short sold. Based on an average daily trading volume, of 1,458,650 shares, the short-interest ratio is currently 0.4 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NextPlat in a report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, NextPlat currently has an average rating of “Sell”.

View Our Latest Stock Report on NXPL

Hedge Funds Weigh In On NextPlat

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC acquired a new stake in NextPlat Corp. (NASDAQ:NXPL – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat as of its most recent SEC filing. 1.30% of the stock is owned by hedge funds and other institutional investors.

NextPlat Stock Performance

Shares of NASDAQ:NXPL traded down $0.01 during trading on Thursday, reaching $0.44. 884,199 shares of the stock were exchanged, compared to its average volume of 1,611,496. NextPlat has a 12 month low of $0.41 and a 12 month high of $1.11. The stock has a 50-day moving average price of $0.59 and a 200-day moving average price of $0.68. The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. The firm has a market cap of $11.95 million, a PE ratio of -1.48 and a beta of 1.26.

NextPlat Company Profile

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

See Also